Publications by authors named "A Delpla"
Purpose: To evaluate the technical feasibility and outcomes of thermal ablation following selective intra-arterial lipiodol injection (SIALI) for targeting primary and secondary liver tumors invisible on ultrasound (US) and non-contrast computed tomography (CT).
Methods: This retrospective study included 18 patients with 20 tumors (67% male, mean age 60.8 ± 12.
Purpose: The purpose of this study was to analyze the intrahepatic perfusion redistribution after embolization of hepatic arterial variants during percutaneous arterial port catheter placement as well as to investigate the treatment efficacy of intraarterial chemotherapy in perfusion redistribution-dependent compared to redistribution-independent liver areas.
Materials And Methods: This retrospective study included 62 patients (67.7% males, mean age of 56 ± 12 years).
Article Synopsis
- The study investigated the feasibility, safety, and effectiveness of intratumoural (IT) immunotherapy in 100 patients, aiming to address resistance and reduce side effects associated with traditional immune checkpoint therapies.
- Researchers documented a variety of patient and tumor characteristics, with most injections targeting superficial lymph nodes and skin lesions, and noted that 72% of patients also received systemic immunotherapy.
- Adverse events occurred in 11.3% of treatment cycles, with mostly mild severity, while response rates showed 5% complete and 18% partial responses, particularly among patients receiving HIT-IT as a first-line treatment.
Purpose: The purpose of this study was to evaluate the safety and efficacy of transarterial chemoembolization (TACE) combined with percutaneous thermal ablation in patients with liver metastases 3 cm in diameter or larger.
Materials And Methods: This retrospective study included 39 patients with a total of 46 liver metastases treated. There were 14 men and 25 women, with a mean age of 55 ± 13.
Objective: The recommended first-line treatment for low-tumor-burden ACC (stage IVa ACC) not amenable to radical resection is mitotane in association with loco-regional treatments (LRs). The aim of this study was to determine the patient population that would benefit the most from LR. Materials and methods: This retrospective monocentric expert center chart review study was performed from 2008 to 2021 and included stage IVa patients (≤2 tumoral organs) treated with LR (either radiotherapy, surgery, or interventional radiology).
View Article and Find Full Text PDF